John B. Amos Cancer Center

Summary

John B. Amos Cancer Center is a medical facility located in Columbus, Georgia. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Breast cancer, Pancreatic Cancer and other specialties. John B. Amos Cancer Center is involved with conducting 209 clinical trials across 326 conditions. There are 1 research doctors associated with this hospital, such as Andrew W. Pippas.

Top PIs

Clinical Trials running at John B. Amos Cancer Center

Colorectal Cancer

Small Cell Lung Cancer

Cancer

Pancreatic Cancer

Lung Cancer

Breast cancer

Melanoma

Cardiotoxicity

Sarcopenia

Non-Small Cell Lung Cancer

Myopenia

for Colorectal Cancer

This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.

Recruiting

1 award

N/A

6 criteria

Cancer Cachexia

for Colorectal, Lung, and Pancreatic Cancer

This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be removed by surgery (unresectable) or is stage IV. Patients with these cancer types are at risk for developing cancer cachexia (CC), which is defined as weight loss, muscle loss, and fat loss due to cancer. CC has been associated with reduced physical performance, impaired quality of life, and poorer survival. Many studies that have evaluated treatments for cancer-related weight and muscle loss have aimed to treat all patients with weight loss exactly the same and, unfortunately, have not been successful. Like different cancer types, weight and muscle loss related to cancer may have different causes in different individuals and the best treatment strategy for this condition may not be a one-size-fits-all approach. Information gathered from this study may help researchers develop new diagnostic criteria for CC and design better treatments and clinical trials for cancer-related weight and muscle loss in the future to improve the quality of life in patients with advanced colorectal, lung, or pancreatic cancer.

Recruiting

1 award

N/A

7 criteria